Form 8-K - Current report:
SEC Accession No. 0001654954-24-011213
Filing Date
2024-08-28
Accepted
2024-08-28 17:09:43
Documents
16
Period of Report
2024-08-28
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K endra_8k.htm   iXBRL 8-K 23762
2 PRESS RELEASE endra_ex991.htm EX-99.1 10635
  Complete submission text file 0001654954-24-011213.txt   161944

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA endra-20240828.xsd EX-101.SCH 5728
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE endra-20240828_lab.xml EX-101.LAB 14667
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE endra-20240828_cal.xml EX-101.CAL 901
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE endra-20240828_pre.xml EX-101.PRE 9278
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE endra-20240828_def.xml EX-101.DEF 2102
18 EXTRACTED XBRL INSTANCE DOCUMENT endra_8k_htm.xml XML 3904
Mailing Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105
Business Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105 734-335-0468
ENDRA Life Sciences Inc. (Filer) CIK: 0001681682 (see all company filings)

EIN.: 260579295 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37969 | Film No.: 241256593
SIC: 3845 Electromedical & Electrotherapeutic Apparatus
(CF Office: 08 Industrial Applications and Services)